..................................................
I will delete posts that are
solicitation from a pump site
or solicitation of us by salesmen
..................................................
$NEXCF at resistance $0.88
OTC/QB avg daily volume (low) 16k website hold x 100% sell filings and news 3/27/2020
$6 million in Revenues Period Ended December 31st 2019
$SHMP looking for a bottom $0.027
OTC/QB - made a ton of money the 1st run ($0.02)
Avg daily Volume 440k
Now looking for a bottom play re entry. A Game Changer stock.
Perfected clean "farming" of salt water shrimp and fish. Website float 300.64m
100% sell filings and news 3/18/20 a fire has destroyed the main building
Note:
We are adopting a policy
of barring and deleting paid humps and the like !!
I will delete any paid promo. They come here to make
some use of our casual stock sharing environment.
Good riddance.
Sign in the entrance window:
We will also delete any so-called market research
advertisement or any post fronting such off-site and
any off-site email sign-up or company solicitation.
< All foreign exchange stocks are welcome so long
as their exchange is clearly shown each posting.
A word to the wise:
"Stock picking is work".
"The stock market
is all about work."
"Just you and it "
We follow stocks with a low float < 100M
and stocks with an ultra low float < 30M.
But whatever is moving well, makes a1list.
Charts qualify that are looking up in some way:
on a moving average at resistance or support,
or with a staging formation such as a bull flag.
An upgrading Pr is great too.
The float shown is the highest number
from OTCMarkets-YahooFinance-WSJournal.
I use the highest of any two I look at.
Re: O/S Checked against SEC filings.
A Patchwork of Gains and Losses Take a look at Grupo Aeroportuario del Sureste, S.A.B. de C.V. (NYSE: ASR), and you’ll see a mixed bag when it comes to October 2026’s passenger traffic. While some regions like Puerto Rico and Colombia took a step forward, others like Mexico and Costa Rica tripped up, resulting in an overall decline of 0.9% compared to last October....
Quarterly Results: The Numbers to Watch Alright, here's the scoop from MCAP Inc.: they just tossed their hat in the quarterly earnings ring, flexing a third quarter EPS of $0.15 a share. Not exactly champagne-popping numbers, but hey, let's not throw out the party favors just yet. Revenues rolled in at a neat $26.7 million, with EBITDA tagging along at $5.2 million. So,...
Another Marker on Pure Hockey's Expansion Path Look, you might not have pegged California as a hockey hotbed a few decades back, but here we are, with Pure Hockey planting yet another flag in El Segundo. It marks their fifth outpost in the Golden State, enhancing access for players in the South Bay area. Makes you think about how far the game’s roots have spread across...
Mark Your Calendars: A Night to Celebrate Listen up, Central Arizona, because I'm giving you the lowdown on Habitat for Humanity Central Arizona's big night out. "Blueprints & Blue Jeans" - it's the gala that's ditching the formalities for some good old-fashioned community fun, but with a seriously important mission at its heart. Mark your calendars for Friday, March 5,...
Connectivity Takes Center Stage in Wuzhen When you throw 1,800 movers and shakers into a room focused on the future of the internet, sparks are gonna fly. That's exactly what's going down at the 2026 World Internet Conference in Wuzhen, China. Brass tacks: this ain't just another snooze-fest. The theme this year screams significance—'Open Source and Openness, Joined...
Labor Standoff at Encore Boston Harbor Ends After a stormy 62 days on the picket lines, around 1,300 workers at Encore Boston Harbor finally find themselves back at their posts, carrying with them the spoils of hard-fought victory. This isn't just a paper contract; it's a banner for worker solidarity. These aren't your run-of-the-mill stock flips, folks; this fight was...
Yiren's Stormy Seas: A Tale of Instability If you're holding a stake in Yiren Digital Ltd. (NYSE: YRD), you're likely feeling the heat right now. It's been a ride down a bumpy road with stock prices taking a nosedive—plummeting 44.05% on news that's got investors seeing red. The Nuts and Bolts of the Class Action What's the big fuss, you ask? Well, the lawsuit is no...
The cosmos isn't just a playground for astronauts. It's a proving ground for the next wave of medical innovation, courtesy of Esperto Medical. They're trotting into uncharted territory with the Translational Research Institute for Space Health (TRISH) grant in hand, determined to transform healthcare both in space and on our own turf. Groundbreaking Tech for Extreme...
Turning the Maple Leaf Over: Teneo's Move Alright, here's the scoop: Teneo is muscling its way north, into Canada, to flex its Financial Advisory chops. With a lineup of 60 professionals already setting the pace across Toronto, Montreal, and Calgary, this move isn’t just smoke—it’s a full-fledged expansion. They're under the hood, tinkering away to beef up...
XCMG's Big Push for Smarter Machinery China's construction machinery titan XCMG just wrapped up a fireworks show of innovation in Xuzhou, highlighting some sharp AI-driven machinery projects. Their recent 'AI + Construction Machinery' competition pulled in minds from over 20 countries, all aiming to rethink how these hulking machines operate. AI and Machinery: A Match...
Menarini Group Shares New Insights on ELZONRIS® at Hematology Meeting The Menarini Group, a leading global pharmaceutical and diagnostics company, is set to showcase new data regarding ELZONRIS® (tagraxofusp-erzs) at a prestigious hematology event, the American Society of Hematology (ASH) Annual Meeting and Exposition. Notable findings from five abstracts, including two...
ALZpath and Siemens Healthineers Form Strategic Partnership ALZpath is thrilled to announce a significant licensing agreement with Siemens Healthineers. This collaboration marks a pivotal enhancement in the accessibility of diagnostic testing for Alzheimer's disease. The agreement involves the use of ALZpath's proprietary pTau217 antibody, a remarkable tool for...
Monte Rosa Therapeutics Presents Groundbreaking Data Cyclin E1-directed molecular glue degraders (MGDs) show considerable potential as a novel therapeutic approach that directly targets a frequently amplified non-enzymatic driver oncogene. This is particularly relevant for multiple solid tumors. Impact of Cyclin E1 MGDs on Tumor Growth Recent data highlight that these...
Unlocking Potential with a Free Resource Nothing beats stepping up your game, especially when it comes to education. Manhattan Review just launched a free SAT vocabulary training tool that’s packing 3,000 words, and it's making waves. This isn’t just a flashy gimmick; it’s a deliberate move to prepare students heading into one of the most important tests of their...
A Journey Through Ancient Chinese Architecture On the fertile grounds where the essence of Chinese civilization flourishes, magnificent ancient architecture tells a story like no other. The beauty of these structures is not just in their design but in the craftsmanship and history infused within each brick and tile. The recent initiative, led by passionate ambassadors of...